Vimarsana
Biggest News Aggregation in the World

Page 13 - Subsequent Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Subsequent Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Subsequent Development Today - Breaking & Trending Today

Valeura Energy delighted with first quarterly report - Vimarsana News

Valeura Energy delighted with first quarterly report

Valeura Energy delighted with first quarterly report

Valeura Energy announces Q1 2023 results and executive leadership changes - Vimarsana News

Valeura Energy announces Q1 2023 results and executive leadership changes

Valeura Energy, the upstream oil and gas company with assets in the Gulf of Thailand and the Thrace Basin of Turkey, has reported its unaudited financial and operating results for the three month period ended March 31, 2023 and changes to its executive leadership team.

WHEN LIBERIA SET A WORLD RECORD FOR "THE MOST RIGGED ELECTION…IN HISTORY" – FrontPageAfrica - Vimarsana News

WHEN LIBERIA SET A WORLD RECORD FOR "THE MOST RIGGED ELECTION…IN HISTORY" – FrontPageAfrica

LIBERIAN GENERAL ELECTIONS OF 1927In 1927, about 95 years ago, the Republic of Liberia (West Africa) held general and presidential elections. In the presidential election, candidates were incumbent Charles Dunbar Burgess King of t

Frontiers | Notch2 Increases the Resistance to Venetoclax-Induced Apoptosis in Chronic Lymphocytic Leukemia B Cells by Inducing Mcl-1 - Vimarsana News

Frontiers | Notch2 Increases the Resistance to Venetoclax-Induced Apoptosis in Chronic Lymphocytic Leukemia B Cells by Inducing Mcl-1

Chronic lymphocytic leukemia (CLL) has experienced a clinical revolution thanks to the discovery of crucial pathogenetic mechanisms. CLL is still an incurable disease due to intrinsic or acquired resistance of the leukemic clone. Venetoclax is a Bcl-2 inhibitor with a marked activity in CLL, but emerging patterns of resistance are being described. We hypothesize that intrinsic features of CLL cells may contribute to drive mechanisms of resistance to venetoclax. We analyzed the expression of IRF4, Notch2 and Mcl-1 in a cohort of CLL patients. We evaluated CLL cells viability after genetic and p...